Infrequent mutation of TRAIL receptor 2 (TRAIL-R2/DR5) in transitional cell carcinoma of the bladder with 8p21 loss of heterozygosity - Concepedia

Concepedia

Publication | Closed Access

Infrequent mutation of TRAIL receptor 2 (TRAIL-R2/DR5) in transitional cell carcinoma of the bladder with 8p21 loss of heterozygosity

25

Citations

67

References

2004

Year

Jacqui Adams, Darren Heavens, Sylvia Bass, Margaret A. Knowles

UrologyTransitional Cell CarcinomaTumor HeterogeneityMedicineGenitourinary CancerTrail Receptor 2PathologyCancer GenomicsInfrequent MutationCancer GeneticsOncologyTumor Biology

References

	Year	Citations

Page 1